首页> 外文期刊>JAMA: the Journal of the American Medical Association >The need for improved access to FDA reviews.
【24h】

The need for improved access to FDA reviews.

机译:需要改善对FDA审查的访问权限。

获取原文
获取原文并翻译 | 示例
           

摘要

THE MEDICAL LITERATURE IS EXPANDING RAPIDLY, WITH thousands of new studies published each year. Increasingly, clinicians and scientists rely on rigorous syntheses of the scientific literature, such as high-quality systematic reviews and meta-analyses, which the Oxford Centre for Evidence-Based Medicine considers the highest level of scientific evidence available. However, systematic reviews and meta-analyses are typically based on the published literature, which is known to be biased, creating an important question: can we trust the highest level of evidence available in MEDLINE?
机译:医学文献正在迅速扩展,每年发表成千上万的新研究。临床医生和科学家越来越多地依靠科学文献的严格综合,例如高质量的系统评价和荟萃分析,牛津循证医学中心认为这是可获得的最高水平的科学证据。但是,系统的综述和荟萃分析通常基于已发表的有偏见的文献,从而提出了一个重要的问题:我们是否可以相信MEDLINE中提供的最高水平的证据?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号